Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blood Recovery Systems, Inc. was a specialized healthcare services and medical device company focused on autologous blood recovery and transfusion solutions. The company provided comprehensive intraoperative and postoperative blood salvage programs, utilizing specialized technology to collect, wash, and reinfuse a patient's own red blood cells during major surgical procedures. This approach is critical for reducing the clinical reliance on donor blood transfusions and minimizing associated risks such as infection or transfusion reactions. In January 1998, the company was acquired by Haemonetics Corporation for approximately $13.5 million. Following the acquisition, its service-based business model and technical expertise were integrated into Haemonetics' broader surgical blood management portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blood Recovery Systems.